Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-8.00 Mil
% of Total Estimate Gain
-29.00%

JNL Multi-Manager U.S. Select Equity Fund's Novo Nordisk AS Holding Summary

As of 2025-03-31, JNL Multi-Manager U.S. Select Equity Fund held - shares of Novo Nordisk AS(NVO), totaling N/A. This investment constitutes 0% of their stock portfolio, and JNL Multi-Manager U.S. Select Equity Fund now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.

The initial trade took place in 2024Q1. And since then JNL Multi-Manager U.S. Select Equity Fund has made 4 purchases of NVO, at an average price of $116.32, for a total of 237,121.00 shares. In addition, there have been 1 sales at an average price of $82.59 for 237,121.00 shares. Based on historical transaction data and NVO's current price of $65.29, JNL Multi-Manager U.S. Select Equity Fund's estimated gain on his NVO holdings is $-8.00 Mil, reflecting a -29.00% gain to date.

JNL Multi-Manager U.S. Select Equity Fund NVO ($65.29) Holding Chart

JNL Multi-Manager U.S. Select Equity Fund NVO ($65.29) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1